Cost-effectiveness analysis of acalabrutinib in treatment of patients with relapsed/refractory form of mantle cell lymphoma who previously received at least one line of therapy

Objective: to conduct a clinical and economic study of acalabrutinib for the treatment of adult patients with relapsed/refractory form of mantle cell lymphoma who previously received at least one line of therapy in the Russian Federation.Material and methods. Acalabrutinib and ibrutinib were conside...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: S. K. Zyryanov (Tekijä), I. N. Dyakov (Tekijä)
Aineistotyyppi: Kirja
Julkaistu: IRBIS LLC, 2024-08-01T00:00:00Z.
Aiheet:
Linkit:Connect to this object online.
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Internet

Connect to this object online.

3rd Floor Main Library

Saatavuus: 3rd Floor Main Library
Hyllypaikka: A1234.567
Nide 1 Saatavissa